Replies to post #1536 on Idenix Pharmaceuticals (IDIX)

[gofishmarko]

>>> my sense is market expectations are low on valtorcitabine <<<

Agreed. It may be priced-in already. A " no-go " might be considered better news than a " go " , if investors perceive it as a rational move to limit cash burn. It still might be better to announce on Fri. evening , so investors have time to think about it for a bit.

;)